EDN1 and diabetes mellitus: Previous studies suggested that ET-1 and ET-R expression were upregulated in the heart of diabetic patients and endothelin receptor antagonists (ERAs), BQ123 and bosentan, protected against diabetes-induced heart injury in human ventricular heart cells [14,15].